logo
Leonard Lauder, philanthropist who globalized family cosmetic business, dies at age 92

Leonard Lauder, philanthropist who globalized family cosmetic business, dies at age 92

Independent16-06-2025
Leonard Lauder, a renowned philanthropist who expanded the family cosmetics business into a worldwide empire, has died at the age of 92.
Estee Lauders Cos. announced the news in a release on Sunday and said he died on Saturday surrounded by family.
Lauder, the oldest son of Estee and Joseph H. Lauder, who founded the company in 1946, formally joined the New York business in 1958. Over more than six decades, Lauder played a key role in transforming the business from a handful of products sold under a single brand in U.S. stores to a multi-brand global giant. He had held the title of chairman emeritus at the time of his death.
Estee Lauder's products are sold in roughly 150 countries and territories under brand names including Clinique and Aveda, according to the company's latest annual report. The company generated sales of nearly $16 billion in the fiscal year ended June 30, 2024, the filing said.
Estee Lauder went public in 1995, but members of Lauder family still have about 84% of the voting power of common stock, according to the latest annual filing.
Lauder served as president of The Estée Lauder Cos. from 1972 to 1995 and as CEO from 1982 through 1999. He was named chairman in 1995 and served in that role through June 2009.
Under his stewardship, Lauder created the company's first research and development laboratory, brought in professional management at every level, and was the impetus behind The Estée Lauder Cos.' international expansion, helping to spearhead the company's sales and profits exponentially, according to the company.
Lauder led the launch of many brands including Aramis, Clinique, and Lab Series, among others. Until his death, he remained deeply involved in the company's acquisition strategy, including the acquisitions of such brands as Aveda, Bobbi Brown, Jo Malone London and MAC, the company said.
During his years as chairman emeritus, Lauder was closely involved in the business and day-to-day operations and was a constant fixture at its global headquarters in New York and at its stores around the world until the time of his death, the company said.
'Throughout his life, my father worked tirelessly to build and transform the beauty industry, pioneering many of the innovations, trends, and best practices that are foundational to the industry today,' said William P. Lauder, son and chair of the board at The Estée Lauder Companies in a statement. 'He was the most charitable man I have ever known, believing that art and education belonged to everyone, and championing the fight against diseases such as Alzheimer's and breast cancer. '
Lauder was a longtime patron of the Metropolitan Museum of Art and, in 2013, pledged his 78-piece collection of Cubist art to the museum in the largest single philanthropic gift in the museum's history. He later added five major works to that pledged gift, the company said.
In concert with his Cubist collection donation, he helped establish the Leonard A. Lauder Research Center for Modern Art at the Met to support a program of fellowships, focused exhibitions, and public lectures. He also was the Whitney Museum of American Art's chairman emeritus and a trustee from 1977 to 2011.
Lauder was married to Evelyn H. Lauder, who had been the senior corporate vice president at the cosmetic company and the founder of the Breast Cancer Research Foundation, from 1959 until she passed away in 2011.
On Jan. 1, 2015, Lauder married Judy Glickman Lauder, a philanthropist and internationally recognized photographer.
Lauder was born in 1933 in New York City. He was a graduate of the Bronx High School of Science, the University of Pennsylvania's Wharton School, and the Officer Candidate School of the United States Navy.
Lauder studied at Columbia University's graduate school of business. He served as a lieutenant in the U.S. Navy and as a Navy reservist, for which the U.S. Navy Supply Corps Foundation later recognized him with its Distinguished Alumni Award.
In addition to his wife and son William, Lauder is survived by his other son Gary M. Lauder and wife, Laura Lauder; five grandchildren, two great-grandchildren, many stepchildren and step grandchildren, as well as his brother, Ronald S. Lauder, and wife, Jo Carole Lauder, and their daughters, Aerin Lauder and Jane Lauder.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Trump administration in talks to take 10% stake in Intel, Bloomberg News reports
Trump administration in talks to take 10% stake in Intel, Bloomberg News reports

Reuters

time18 minutes ago

  • Reuters

Trump administration in talks to take 10% stake in Intel, Bloomberg News reports

Aug 18 (Reuters) - The Trump administration is in talks to take a 10% stake in Intel by converting some or all of the struggling company's Chips Act grants into equity, Bloomberg News reported, citing a White House official and other people familiar with the matter. Shares of Intel (INTC.O), opens new tab fell about 3% on Monday, after rallying last week on hopes of U.S. federal support. A 10% stake in the American chipmaker would be worth about $10 billion. Intel has been slated to receive a combined $10.9 billion in Chips Act grants for commercial and military production, and the figure is roughly enough to pay for the government's holding, according to the Bloomberg report on Monday. Intel declined to comment on the report, while the White House did not respond to a request for comment. Reuters could not immediately verify the report. Media reports said last week that the U.S. government may buy a stake in Intel, after a meeting between CEO Lip-Bu Tan and President Donald Trump that was sparked by Trump's demand for the new Intel chief's resignation over his ties to Chinese firms. Federal backing could give Intel more breathing room to revive its loss-making foundry business, analysts have said, but it still suffers from a weak product roadmap and challenges in attracting customers to its new factories. "The fact that the U.S. government is stepping in to save a blue-chip American company likely means that Intel's competitive position was much worse than what anybody feared," said David Wagner, head of equity and portfolio manager at Intel shareholder Aptus Capital Advisors. Wagner added that while he was skeptical about the U.S. government investing taxpayer money into U.S. companies, it was better than having Intel become a state-owned entity. Aptus Capital Advisors holds 80,581 shares of Intel. Trump, who said the meeting with Tan was "very interesting" one, has taken an unprecedented approach to corporate interventions. He has pushed for multibillion-dollar government tie-ups in semiconductors and rare earths, such as a pay-for-play deal with Nvidia (NVDA.O), opens new tab and an arrangement with rare earth producer MP Materials (MP.N), opens new tab to secure critical minerals. The U.S. government has previously taken equity stakes in companies under stress. During the 2007-2009 financial crisis, it took a stake in General Motors (GM.N), opens new tab — later exiting the stake in 2013. Intel last year secured nearly $8 billion in subsidies, the largest outlay under the act, to build new factories in Ohio and other states as former CEO Pat Gelsinger bet on them to restore the company's manufacturing edge. Tan, however, pared back such ambitions, slowing construction in Ohio. He plans to build factories based on demand for the services, which analysts have said could put him at odds with Trump's push to shore up American manufacturing.

Gold prices steady as investors assess Trump–Zelenskiy meeting
Gold prices steady as investors assess Trump–Zelenskiy meeting

Reuters

time36 minutes ago

  • Reuters

Gold prices steady as investors assess Trump–Zelenskiy meeting

Aug 18 (Reuters) - Gold prices were largely steady on Monday, as investors focused on U.S. President Donald Trump's meeting with Ukrainian and European leaders, and the Federal Reserve's annual symposium in Jackson Hole this week. Spot gold was marginally down at $3,333.32 per ounce at 01:42 p.m. ET (1742 GMT), after hitting its lowest level since August 1 earlier in the session. U.S. gold futures for December delivery settled 0.1% lower at $3,378. The U.S. dollar gained 0.3%, making greenback-priced bullion more expensive for other currency holders. Trump said the U.S. would "help out" Europe in providing security for Ukraine as part of any deal to end Russia's war in Ukraine, as he and President Volodymyr Zelenskiy began a hastily arranged White House meeting to discuss a path to peace. The European leaders will meet with Trump afterwards in the White House's East Room at 3 p.m. EDT (1900 GMT), according to the White House. The meeting between Trump and Zelenskiy follows Trump's meeting with Putin on Friday, where the two leaders agreed to pursue a peace deal without implementing a ceasefire. "There was not much reaction in gold to the Putin-Trump meeting. I think we'll continue in this price range. The next inflection point is the Federal Reserve (conference)," said Marex analyst Edward Meir. Minutes from the U.S. central bank's July policy meeting are due on Wednesday, ahead of the Fed's annual conference in Jackson Hole, Wyoming, scheduled for August 21–23. Fed Chair Jerome Powell is expected to speak at the event. Investors will be watching out for Powell's remarks on the economic outlook. While markets have already priced in a 25 basis point cut, there's an outside chance of a 50 basis point reduction, which could drive gold prices higher, Meir said. Gold tends to perform strongly in environments with low interest rates and heightened uncertainty. Elsewhere, spot silver rose 0.1% at $38.02 per ounce, while platinum fell 0.1% to $1,334.10. Spot palladium gained 1% to $1,122.86 after falling to its lowest level since July 10 earlier in the session.

CVS cannot obtain AIG, Chubb opioid coverage, top Delaware court rules
CVS cannot obtain AIG, Chubb opioid coverage, top Delaware court rules

Reuters

timean hour ago

  • Reuters

CVS cannot obtain AIG, Chubb opioid coverage, top Delaware court rules

Aug 18 (Reuters) - CVS Health (CVS.N), opens new tab is not entitled to coverage from insurers, including AIG (AIG.N), opens new tab and Chubb , against thousands of lawsuits over its role in the nation's opioid crisis, Delaware's highest court ruled on Monday. The Delaware Supreme Court concluded that governments, hospitals, doctors and benefit plans that sued CVS sought damages for economic losses, not individualized "bodily injury" or "property damage" covered by CVS' general liability policies. It also rejected the argument that CVS' $5 billion nationwide settlement of opioid claims in November 2022 showed that the pharmacy chain and benefits manager had been sued for bodily injury. "The national settlement agreement funds expenses in response to the opioid crisis at-large, but it does not change the fact that the underlying lawsuits do not seek specific damages tied to individualized injuries," Chief Justice Collins Seitz wrote for a unanimous court. Neither CVS nor its lawyers immediately responded to requests for comment. AIG, Chubb and their lawyers did not immediately respond to similar requests. Many insurers have been sued by pharmacy chains, drugmakers and others seeking coverage for opioid-related bills. Chains had long argued they were merely filling doctors' prescriptions, but critics said the large quantities being dispensed and the potential for diversion were red flags. Walgreens (WBA.O), opens new tab and Walmart, opens new tab(WMT.N), opens new tab agreed to pay more than $8 billion in similar settlements. CVS, based in Woonsocket, Rhode Island, had been appealing two Delaware Superior Court decisions denying insurance coverage in more than 2,300 lawsuits, according to Monday's decision. Governments complained about increased spending to treat opioid addiction, hospitals reported strains on their health systems, and third-party payors such as employee benefit funds cited costs of prescription purchases and addiction treatment. The Delaware Supreme Court ruled in Chubb's favor in a similar case involving Rite Aid in 2022. CVS claimed that its own policies offered broader coverage, but the court found the policies "similar in all material respects" to Rite Aid's. The case is In re CVS Opioid Insurance Litigation, Delaware Supreme Court, No. 482.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store